In Brief: Fujisawa USA's clonidine injection
Executive Summary
Fujisawa USA's clonidine injection: Epidural clonidine NDA filed Aug. 7, company reports. The alpha-2 partial adrenergic agonist would be indicated for treatment of severe pain in cancer patients when used together with opiate-based drugs. Fujisawa USA has been granted orphan drug status for clonidine for "continuous epidural administration as adjunctive therapy with intraspinal opiates for the treatment of pain in cancer patients tolerant to or unresponsive to intraspinal opiates alone"...